China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.
From headphones that can tell the age of your brain to a headband that can help rewire your brain, consumer neurotechnology devices are unraveling the mysteries of the mind ...
Hosted on MSN
My brain is not braining
Magic tricks and hacks you're not ready to watch ‘We are witnessing a full-blown cover-up’: Rep. Raskin responds to DOJ release of Epstein files Enormous freshwater reservoir discovered off the East ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. SEE ALSO: 'Shrinking' ...
Jan 27 (Reuters) - The executive board of the International Monetary Fund on Tuesday approved the sixth and final review of Zambia's extended credit facility, it said in a statement, paving the way ...
IQ Blast Pro Reviews 2026: Doctors and Neuroscientists Reveal the Truth Behind This Cognitive Enhancement Breakthrough That Targets Gamma-Wave Activation, BDNF Boosting, and Neuroplastic Repair for ...
Gamers might soon be able to scan their brains using specialized commercial headphones to get midmatch snapshots of mental performance. David Lumb is a senior reporter covering mobile and gaming ...
OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain-computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a new competitor to Elon Musk’s Neuralink, ...
Department of War Secretary Pete Hegseth said the Pentagon is reviewing the Small Business Administration’s 8(a) Business Development Program, arguing that the long-running initiative has strayed from ...
Hosted on MSN
This device turns brain signals into software
The neural interface doesn’t read thoughts in a sci-fi sense, but it does translate brain signals into usable output. By detecting patterns in brain waves, the system can predict intent. That intent ...
SAN FRANCISCO, Jan 16 (Reuters) - More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results